CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.

MLA

Yuan, Xueying, et al. “CREB-Binding Protein/P300 Bromodomain Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in Triple-Negative Breast Cancer.” JCI Insight, vol. 9, no. 20, Sept. 2024. EBSCOhost, https://doi.org/10.1172/jci.insight.182621.

APA

Yuan, X., Hao, X., Chan, H. L., Zhao, N., Pedroza, D. A., Liu, F., Le, K., Smith, A. J., Calderon, S. J., Lieu, N., Soth, M. J., Jones, P., Zhang, X. H., & Rosen, J. M. (2024). CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight, 9(20). https://doi.org/10.1172/jci.insight.182621

Chicago

Yuan, Xueying, Xiaoxin Hao, Hilda L Chan, Na Zhao, Diego A Pedroza, Fengshuo Liu, Kang Le, et al. 2024. “CREB-Binding Protein/P300 Bromodomain Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in Triple-Negative Breast Cancer.” JCI Insight 9 (20). doi:10.1172/jci.insight.182621.